Sirtris Pharmaceuticals

PharmaceuticalsSeries CCambridge, USsirtrispharma.com

Latest round

Series C

Last raised

Mar 2006

Total raised

$67M

Investors

17

About Sirtris Pharmaceuticals

Founded in 2004, Sirtris Pharmaceuticals is based in Cambridge, US, specializing in health product development. The company underwent a significant shift when it was acquired by GlaxoSmithKline in April 2008 for USD 720 mn. It has executed a total of 7 deals, with its most recent deal occurring on May 23, 2007.Sirtris Pharma specializes in the development and commercialization of health and wellness products, with a focus on nutritional supplements and over-the-counter medications. Their flagship product, Solgar Magnesium Citrate, is recognized for its bioavailability.In the most recent year, 2007, Sirtris Pharma reported a revenue of USD 0 and an EBITDA of USD -34,564,000.00 per share, the company was subsequently acquired by GlaxoSmithKline in April 2008 for USD 720 mn. Future initiatives are focused on expanding their product line and entering new markets, although specific products and timelines have not been detailed in the current data.

Who invested in Sirtris Pharmaceuticals

17 investors across 4 rounds

See all investors in Sirtris Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Mar 14, 2006

    Amount

    $22M

    Investors

    Locked

  2. Series B

    Mar 7, 2005

    Amount

    $27M

    Investors

    Locked

  3. Series A

    Nov 17, 2004

    Amount

    $13M

    Investors

    Locked

  4. Series A

    Aug 16, 2004

    Amount

    $5M

    Investors

    Locked

Questions about Sirtris Pharmaceuticals

Who invested in Sirtris Pharmaceuticals?

Sirtris Pharmaceuticals has 17 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Sirtris Pharmaceuticals raised?

Sirtris Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Sirtris Pharmaceuticals last raise money?

Sirtris Pharmaceuticals's most recent round on record is a Series C, in Mar 2006.

What does Sirtris Pharmaceuticals do?

Founded in 2004, Sirtris Pharmaceuticals is based in Cambridge, US, specializing in health product development.

Where is Sirtris Pharmaceuticals headquartered?

Sirtris Pharmaceuticals is headquartered in Cambridge, US.

Which VCs invest in companies like Sirtris Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Sirtris Pharmaceuticals's stage. Their profiles are linked below.

Raising like Sirtris Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.